| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $23.20B | +11.8% |
| Cost of Revenue | $14.76B | +6.5% |
| R&D Expense | $754.0M | +13.4% |
| SG&A Expense | $3.79B | +17.6% |
| Pre-tax Income | $3.83B | +31.5% |
| Income Tax | $604.0M | +35.7% |
| Net Income | $3.22B | +30.7% |
| EPS (Basic) | $8.06 | +30.6% |
| EPS (Diluted) | $8.02 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $488.0M | +66.0% |
| Short-term Investments | $2.12B | +712.6% |
| Accounts Receivable | $4.47B | +9.8% |
| Inventory | $3.74B | +9.0% |
| Current Assets | $11.68B | +33.5% |
| Total Assets | $38.43B | +9.8% |
| Current Liabilities | $7.75B | +21.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.62B | +43.1% |
| Capital Expenditures | $757.0M | +26.6% |
| Investing Cash Flow | -$2.58B | -114.6% |
| Financing Cash Flow | -$871.0M | +35.0% |
| Free Cash Flow | $2.87B | +48.2% |
| +30.6% |
| Long-term Debt |
| $9.26B |
| +11.2% |
| Stockholders' Equity | $19.04B | +11.7% |